Coldstream Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$792K Buy
11,766
+596
+5% +$39.7K 0.01% 560
2026
Q1
$701K Buy
11,170
+5,332
+91% +$371K 0.01% 580
2025
Q4
$387K Sell
5,838
-2,601
-31% -$168K 0.01% 816
2025
Q3
$568K Sell
8,439
-125
-1% -$9.89K 0.01% 688
2025
Q2
$748K Sell
8,564
-2,446
-22% -$192K 0.01% 499
2025
Q1
$752K Sell
11,010
-2,105
-16% -$172K 0.02% 447
2024
Q4
$1.02M Buy
13,115
+1,862
+17% +$138K 0.02% 377
2024
Q3
$781K Buy
11,253
+3,508
+45% +$288K 0.02% 451
2024
Q2
$878K Buy
7,745
+1,274
+20% +$161K 0.02% 355
2024
Q1
$898K Buy
6,471
+336
+5% +$42.2K 0.02% 351
2023
Q4
$761K Buy
6,135
+1,660
+37% +$170K 0.02% 361
2023
Q3
$418K Sell
4,475
-998
-18% -$113K 0.01% 501
2023
Q2
$703K Buy
5,473
+4
+0.1% +$484 0.02% 340
2023
Q1
$635K Sell
5,469
-17
-0.3% -$1.9K 0.02% 364
2022
Q4
$621K Buy
+5,486
New +$602K 0.02% 363
2022
Q2
$281K Buy
3,768
+788
+26% +$71.9K 0.01% 587
2022
Q1
$381K Sell
2,980
-736
-20% -$80.5K 0.01% 475
2021
Q4
$499K Buy
+3,716
New +$534K 0.02% 427

Other funds holding DXCM

Coldstream Capital Management's DXCM Position: Q2 2026 in Review

Coldstream Capital Management increased its DexCom (DXCM) stake by 5.3% in Q2 2026, buying an estimated $39.7K and bringing the position to 11,766 shares worth $792K. The position accounts for 0.01% of the portfolio, ranked #560.

Coldstream Capital Management first reported a position in DXCM in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.02M in Q4 2024. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Coldstream Capital Management held 11,766 shares of DexCom worth $792K as of Q2 2026.
  • Coldstream Capital Management bought 596 DexCom shares in Q2 2026, an estimated $39.7K.
  • DexCom made up 0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #560 holding.
  • Coldstream Capital Management first reported a position in DexCom in Q4 2021 and has held it in 18 quarters since.
  • Coldstream Capital Management's DexCom position peaked at $1.02M in Q4 2024.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.